177 related articles for article (PubMed ID: 9816030)
1. Association between high levels of ornithine decarboxylase activity and favorable prognosis in human colorectal carcinoma.
Matsubara N; Hietala OA; Gilmour SK; Yum KY; Litwin S; Watts P; Brennan ; O'Brien
Clin Cancer Res; 1995 Jun; 1(6):665-71. PubMed ID: 9816030
[TBL] [Abstract][Full Text] [Related]
2. Properties of ornithine decarboxylase in human colorectal adenocarcinomas.
Hietala OA; Yum KY; Pilon J; O'Donnell K; Holroyde CP; Kline I; Reichard GA; Litwin S; Gilmour SK; O'Brien TG
Cancer Res; 1990 Apr; 50(7):2088-94. PubMed ID: 2317797
[TBL] [Abstract][Full Text] [Related]
3. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
Tatsumoto N; Hiyama E; Murakami Y; Imamura Y; Shay JW; Matsuura Y; Yokoyama T
Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
[TBL] [Abstract][Full Text] [Related]
4. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
[TBL] [Abstract][Full Text] [Related]
5. Relationship of ornithine decarboxylase activity and human colon tumorigenesis.
Takami H; Koudaira H; Kodaira S
Jpn J Clin Oncol; 1994 Jun; 24(3):141-3. PubMed ID: 8007423
[TBL] [Abstract][Full Text] [Related]
6. Change in telomerase activity during human colorectal carcinogenesis.
Yoshida R; Kiyozuka Y; Ichiyoshi H; Senzaki H; Takada H; Hioki K; Tsubura A
Anticancer Res; 1999; 19(3B):2167-72. PubMed ID: 10472326
[TBL] [Abstract][Full Text] [Related]
7. Ornithine decarboxylase activity in the rat and human colon.
Rozhin J; Wilson PS; Bull AW; Nigro ND
Cancer Res; 1984 Aug; 44(8):3226-30. PubMed ID: 6430547
[TBL] [Abstract][Full Text] [Related]
8. Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa.
Hixson LJ; Garewal HS; McGee DL; Sloan D; Fennerty MB; Sampliner RE; Gerner EW
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):369-74. PubMed ID: 8348060
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
10. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
[TBL] [Abstract][Full Text] [Related]
11. Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and grade.
Weiss TS; Bernhardt G; Buschauer A; Thasler WE; Dolgner D; Zirngibl H; Jauch KW
Int J Colorectal Dis; 2002 Nov; 17(6):381-7. PubMed ID: 12355213
[TBL] [Abstract][Full Text] [Related]
12. Supplemental calcium suppresses colonic mucosal ornithine decarboxylase activity in elderly patients with adenomatous polyps.
Lans JI; Jaszewski R; Arlow FL; Tureaud J; Luk GD; Majumdar AP
Cancer Res; 1991 Jul; 51(13):3416-9. PubMed ID: 1711410
[TBL] [Abstract][Full Text] [Related]
13. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
[TBL] [Abstract][Full Text] [Related]
14. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
15. Heterogenicity of ornithine decarboxylase during mouse colon carcinogenesis and in human colon tumors.
Sumiyoshi H; Baer AR; Wargovich MJ
Cancer Res; 1991 Apr; 51(8):2069-72. PubMed ID: 2009526
[TBL] [Abstract][Full Text] [Related]
16. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry.
Fietkau R; Zettl H; Klöcking S; Kundt G
Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968
[TBL] [Abstract][Full Text] [Related]
17. Levels of colorectal ornithine decarboxylase activity in patients with colon cancer, a family history of nonpolyposis hereditary colorectal cancer, and adenomas.
Love RR; Surawicz TS; Morrissey JF; Verma AK
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):195-8. PubMed ID: 1306105
[TBL] [Abstract][Full Text] [Related]
18. Sources of variability in estimating ornithine decarboxylase activity and polyamine contents in human colorectal mucosa.
Hixson LJ; Emerson SS; Shassetz LR; Gerner EW
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):317-23. PubMed ID: 8061580
[TBL] [Abstract][Full Text] [Related]
19. The role of thymidylate synthase levels in the prognosis and the treatment of patients with colorectal cancer.
Sanguedolce R; Vultaggio G; Sanguedolce F; Modica G; Li Volsi F; Diana G; Guereio G; Bellanca L; Rausa L
Anticancer Res; 1998; 18(3A):1515-20. PubMed ID: 9673363
[TBL] [Abstract][Full Text] [Related]
20. Ornithine decarboxylase as a marker for colorectal polyps and cancer.
Luk GD; Moshier JA; Ehrinpreis MN
Prog Clin Biol Res; 1988; 279():227-39. PubMed ID: 3054922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
